RICHMOND VANADIUM TECHNOLOGY LIMITED — Director's Dealing 2022

Dec 19, 2022

ASX ANNOUNCEMENT 19/12/2022

AMENDED APPENDIX 3Y - CHANGE OF DIRECTOR’S INTEREST NOTICE

We attach the Change of Director’s Interest Notice (Appendix 3Y) for the following director:

• Dr Shuang (Shaun) Ren – Managing Director

Authorised by the Board.

For more information:

Julian Tambyrajah Chief Financial Officer & Joint Company Secretary Julian.tambyrajah@richmondvanadium.com.au

Page 1 of 1 | ACN 617 799 738 Level 11, 251 Adelaide Terrace, Perth WA 6000 info@richmondvanadium.com.au | www.richmondvanadium.com.au

ASX Code: RVT

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Richmond Vanadium Technology Ltd ABN 63 617 799 738

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Shuang Kui Ren
Date of last notice	13 December 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Shares held by Weiping Ren (spouse)
Date of change		13 - 16 December 2022
No. of securities held prior to change		Direct Interest 3,989,339 Ordinary fully paid shares, comprising: •2,350,841 ordinary fully paid shares (freely tradeable); •1,596,911 ordinary fully paid shares (escrowed for 24 months from date of official quotation); and •41,587 ordinary fully paid shares distributed as an in-specie distribution (escrowed for 24 months from date of official quotation) 500,000 Unlisted performance rights expiring on 5 December 2024 (escrowed for 24 months from date of official quotation) 2,500,000 Unlisted options exercisable at $0.50 per option expiring on 5 December 2024 (escrowed for 24 months from date of official quotation)

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

		Indirect interest 5,102,665 Ordinary fully paid shares, comprising: •1,034,682 ordinary fully paid shares (freely tradeable); •4,050,000 ordinary fully paid shares (escrowed for 24 months from date of official quotation); and •17,983 ordinary fully paid shares distributed as an in-specie distribution (escrowed for 24 months from date of official quotation)
Class		Ordinary Shares
Number acquired		150,000 (direct) 100,000 (indirect)
Number disposed		Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		$80,067.69
No. of securities held after change		Direct Interest 4,139,339 Ordinary fully paid shares, comprising: •2,500,841 ordinary fully paid shares (freely tradeable); •1,596,911 ordinary fully paid shares (escrowed for 24 months from date of official quotation); and •41,587 ordinary fully paid shares distributed as an in-specie distribution (escrowed for 24 months from date of official quotation) 500,000 Unlisted performance rights expiring on 5 December 2024 (escrowed for 24 months from date of official quotation) 2,500,000 Unlisted options exercisable at $0.50 per option expiring on 5 December 2024 (escrowed for 24 months from date of official quotation) Indirect interest 5,202,665 Ordinary fully paid shares, comprising: •1,134,682 ordinary fully paid shares (freely tradeable); •4,050,000 ordinary fully paid shares (escrowed for 24 months from date of official quotation); and •17,983 ordinary fully paid shares distributed as an in-specie distribution (escrowed for 24 months from date of official quotation)

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue On-Market Trade of securities under dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not Applicable
Nature of interest	Not Applicable
Name of registered holder (if issued securities)	Not Applicable
Date of change	Not Applicable
No. and class of securities to which interest related prior to change Note: Details are onlyrequired for a contract in relation to which the interest has changed	Not Applicable
Interest acquired	Not Applicable
Interest disposed	Not Applicable
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Not Applicable
Interest after change	Not Applicable
Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade toproceed during thisperiod?	Not Applicable
If prior written clearance was provided, on what date was thisprovided?	Not Applicable

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3